Literature DB >> 10564812

Cloning of a Leishmania major gene encoding for an antigen with extensive homology to ribosomal protein S3a.

K Zemzoumi1, E Guilvard, D Sereno, A Preto, M Benlemlih, A C Da Silva, J L Lemesre, A Ouaissi.   

Abstract

Following purification by affinity chromatography, a Leishmania major S-hexylglutathione- binding protein of molecular mass 66kDa was isolated. The immune serum against the parasite 66kDa polypeptide when used to screen a L. major cDNA library could identify clones encoding for the human v-fos transformation effector homologue, namely ribosomal protein S3a, and thus was named LmS3a-related protein (LmS3arp). A 1027bp cDNA fragment was found to contain the entire parasite gene encoding for a highly basic protein of 30kDa calculated molecular mass sharing homology to various ribosomal S3a proteins from different species. Using computer methods for a multiple alignment and sequence motif search, we found that LmS3arp shares a sequence homology to class theta glutathione S-transferase mainly in a segment containing critical residues involved in glutathione binding. These new findings are discussed in the light of recent published data showing multiple function(s) of the ribosomal proteins S3a.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564812     DOI: 10.1016/s0378-1119(99)00433-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation.

Authors:  A Cordeiro-Da-Silva; M C Borges; E Guilvard; A Ouaissi
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family.

Authors:  J S Smith; C B Brachmann; I Celic; M A Kenna; S Muhammad; V J Starai; J L Avalos; J C Escalante-Semerena; C Grubmeyer; C Wolberger; J D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.